No Data
Hong Kong stock concept tracking | The USA AACR 2025 conference is approaching, and Institutions are focusing on the development trends of Innovative Drugs (with related stocks attached).
The AACR Annual Meeting will be held in Chicago, USA from April 25 to 30, 2025.
CKLIFE SCIENCES (00775) will present the latest data on its preclinical research of cancer vaccines at the USA Cancer Research Association's Annual Meeting in 2025.
CKLIFE SCIENCES (00775) announced that the company will hold an event at the American Association for Cancer Research (AACR) in Chicago, USA...
CKLIFE SCIENCES (00775.HK): Breakthrough in cancer vaccine technology, waiting for the "big bomb" to be unveiled.
Recently, CKLIFE SCIENCES (00775.HK), which is listed on the Hong Kong stock exchange, issued an announcement after a brief suspension of trading, leading to a significant increase in its stock price. On April 11, the opening price surged by as much as 42%, and over the next two days continued to soar, rising by 16% and 11% respectively, with an overall increase of 68% over four trading days. According to this announcement from CKLIFE SCIENCES, it reported good early results in pre-clinical laboratory tests for a novel cancer vaccine targeting trophoblast cell surface antigen 2 (TROP2). Clearly, the surge in stock price reflects the market's rational pricing of the company's technological breakthroughs.
CKLIFE SCIENCES: Annual Report 2024
Hong Kong stocks fluctuate | CKLIFE SCIENCES (00775) rose over 11% again at the close. The company expects the commercialization of the TROP2 cancer vaccine to bring significant potential economic benefits.
CKLIFE SCIENCES (00775) increased by more than 11% in the late trading session, with an accumulated rise of over 60% in the last three days. As of the time of writing, it has risen by 9.86%, priced at 0.78 HKD, with a trading volume of 32.1451 million HKD.
CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
Investors Don't See Light At End Of CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Tunnel And Push Stock Down 26%
